Case report demonstrates disease-free survival and functional independence after urethrectomy and Mitrofanoff urinary diversion for primary vaginal melanoma, highlighting the value of tailored...
Primary vaginal malignant melanoma is an extremely rare and aggressive cancer, accounting for less than 3% of melanomas involving the female genital tract. Due to its nonspecific presentation, diagnosis is often delayed, and no standardized treatment protocol exists. A 63-year-old postmenopausal woman presented with persistent vaginal discharge, anorexia, and weight loss. Clinical evaluation and biopsy of a vaginal lesion revealed malignant melanoma. Magnetic resonance imaging demonstrated vaginal and urethral involvement. Histopathology revealed malignant melanoma, positive for S-100, SOX-10, vimentin, and focal HMB-45. Following a multidisciplinary evaluation, she underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, total vaginectomy, urethrectomy, and Mitrofanoff (appendicovesicostomy) urinary diversion. Histopathology confirmed melanoma with a Breslow thickness of 4 mm and negative margins. She received adjuvant pelvic radiotherapy and was trained in clean intermittent self-catheterization (CISC). At 33 months post-treatment, the patient remains disease-free and functionally independent, with successful CISC. This case emphasizes the role of individualized surgical planning and continent urinary reconstruction following urethrectomy in the management of locally advanced vaginal melanoma. A multidisciplinary approach and individualized intervention are essential to optimize outcomes in such rare gynecologic malignancies.
No takes yet. Share an insight, caveat, or question.
Ahlawat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: